Josh Jin, Ph.D., is an Investment Manager with Lilly Asia Ventures (LAV). Prior to joining LAV, Josh was a Consultant at Boston Consulting Group (BCG) Shanghai office, helping biopharma companies and private equity firms on various corporate strategy and equity investment related topics. Prior to BCG, Josh worked at Syneos Health New York office as an Associate Consultant on pricing and market access. Josh holds Ph.D. in Genetics from Yale University and B.S. in Biotechnology from Fudan University.